Revenue, 2025
USD 109.58 Bn
Forecast Year, 2034
USD 164.44 Bn
CAGR, 2025 - 2034
4.14%
Report Coverage
Worldwide
The global anti-inflammatory therapeutics market was valued at USD 109.58 billion in 2025 and is expected to reach approximately USD 164.44 billion by 2034, expanding at a CAGR of 4.14%, driven by rising chronic inflammatory disorders, aging populations, and ongoing advancements in drug development.
Anti-Inflammatory Therapeutics Market Size Analysis
Anti-Inflammatory Therapeutics Market Size By Drug Class 2025 to 2034 (USD Billion)
| Drug Class | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Anti-inflammatory Biologics | 41.64 | 43.71 | 45.87 | 48.14 | 50.52 | 53.02 | 55.63 | 58.37 | 61.24 | 64.25 |
| NSAIDs | 46.02 | 47.70 | 49.44 | 51.24 | 53.10 | 55.03 | 57.03 | 59.10 | 61.24 | 63.46 |
| Corticosteroids | 21.92 | 22.71 | 23.53 | 24.38 | 25.26 | 26.17 | 27.12 | 28.09 | 29.11 | 30.15 |
Anti-Inflammatory Therapeutics Market Size By Indication 2025 to 2034 (USD Billion)
| Indication | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Arthritis | 37.26 | 38.91 | 40.64 | 42.45 | 44.33 | 46.31 | 48.36 | 50.51 | 52.75 | 55.10 |
| Respiratory Diseases | 23.01 | 23.85 | 24.72 | 25.62 | 26.55 | 27.52 | 28.52 | 29.55 | 30.62 | 31.73 |
| Multiple Sclerosis | 13.15 | 13.75 | 14.38 | 15.04 | 15.72 | 16.44 | 17.19 | 17.98 | 18.80 | 19.65 |
| Psoriasis | 12.05 | 12.59 | 13.14 | 13.72 | 14.33 | 14.97 | 15.63 | 16.32 | 17.04 | 17.79 |
| Inflammatory Bowel Disease | 14.25 | 14.92 | 15.62 | 16.35 | 17.12 | 17.92 | 18.76 | 19.64 | 20.56 | 21.52 |
| Other Inflammatory Diseases | 9.86 | 10.10 | 10.34 | 10.58 | 10.83 | 11.07 | 11.32 | 11.57 | 11.82 | 12.08 |
Anti-Inflammatory Therapeutics Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 44.93 | 46.56 | 48.25 | 50.00 | 51.81 | 53.69 | 55.63 | 57.64 | 59.73 | 61.89 |
| Europe | 29.59 | 30.70 | 31.85 | 33.04 | 34.28 | 35.57 | 36.90 | 38.28 | 39.72 | 41.20 |
| Asia Pacific | 24.11 | 25.45 | 26.86 | 28.34 | 29.90 | 31.54 | 33.27 | 35.08 | 36.99 | 38.99 |
| Latin America | 6.57 | 6.90 | 7.25 | 7.61 | 7.99 | 8.39 | 8.81 | 9.24 | 9.70 | 10.18 |
| Middle East & Africa | 4.38 | 4.51 | 4.63 | 4.76 | 4.90 | 5.03 | 5.17 | 5.31 | 5.46 | 5.60 |
Anti-Inflammatory Therapeutics Market Size to Worth USD 164.44 Billion by 2034
The anti-inflammatory therapeutics market size was estimated at USD 109.58 bn in 2025 and is projected to be worth around USD 164.44 bn by 2034 a CAGR of 4.14%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com